Does Lean Show Up in a Drug Test? The Science

Lean will show up on a standard drug test, and it can trigger positive results on more than one panel. The drink’s main active ingredient, codeine, is an opiate that your body partly converts into morphine, so it flags the opiate portion of a routine urine screen. What catches many people off guard is that promethazine, the antihistamine that gives lean its sedating kick, can separately trigger a false positive for amphetamines on certain immunoassay tests. The science behind detection is more layered than a simple yes-or-no, and the details matter if you are facing a workplace, probation, or athletic drug test.

What Lean Actually Contains

Lean goes by several street names, including purple drank, sizzurp, and dirty sprite. At its core, it is prescription-strength cough syrup mixed into a soft drink, sometimes with hard candy dissolved in for sweetness. The cough syrup formulation that defines lean typically contains two drugs: codeine, an opioid painkiller, and promethazine, a first-generation antihistamine with strong sedative properties. When researchers used gas chromatography-mass spectrometry to analyze confiscated samples, they found codeine concentrations around 130 mg per liter and promethazine around 68 to 75 mg per liter, with some samples also containing dihydrocodeine or trace cocaine impurities.¹ Those concentrations are well within pharmacologically active ranges, meaning even a single cup of lean delivers a real drug dose.

One reason lean is sometimes treated casually is that codeine sits at the milder end of the opioid spectrum. But mild is relative. Your liver converts codeine into morphine using an enzyme called CYP2D6, and morphine is one of the most potent opioid agonists known.² Once that conversion happens, the body is dealing with the same compound that heroin breaks down into. Drug tests do not care whether the morphine in your urine came from a prescription cough syrup or an illegal street drug. Morphine is morphine.

How Codeine Flags the Opiate Panel

Most workplace and forensic drug tests in the United States follow a two-step process. The first step is an immunoassay screen, a quick chemical test that checks urine against a panel of drug classes. Standard panels include opiates as one of the core categories. Immunoassays work by detecting molecules that fit a certain chemical shape, and both codeine and morphine fit the opiate shape easily. If you have consumed lean recently, the opiate section of the screen will almost certainly come back positive.

The standard cutoff concentration for a positive opiate result is 300 nanograms per milliliter in urine for many commonly used immunoassays. A single serving of lean, given the codeine concentrations found in analyzed samples, delivers enough codeine to produce metabolites well above that threshold. The test does not distinguish between codeine and morphine at this stage. It simply flags the sample as opiate-positive and sends it for confirmation.

Confirmatory testing, the second step, uses more precise instruments like gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry. These methods can identify the exact molecules present and their concentrations, separating codeine from morphine, from hydrocodone, from oxycodone, and so on. A lean user’s confirmatory result will typically show both codeine and morphine, because the body naturally converts a portion of codeine into morphine. The ratio of morphine to codeine in the urine sample gives toxicologists a clue about what was actually consumed, a detail that becomes important when distinguishing lean use from poppy seed ingestion or other sources of opiates.

Promethazine and False-Positive Amphetamine Results

This is the part that surprises most people. Promethazine belongs to a drug class called phenothiazines, and these molecules happen to share enough structural similarity with amphetamines that they can fool certain immunoassay kits. In a study that looked specifically at patients taking promethazine, over a third tested falsely positive for amphetamines on one widely used immunoassay platform, and nearly two-thirds showed meaningful cross-reactivity with the test’s antibodies.³

That means a person who drinks lean could walk into a drug test and get flagged not just for opiates but also for amphetamines, even though they never touched anything in the amphetamine family. If the test stops at the immunoassay stage, as some rapid workplace panels do, the result would show two presumptive positives. The amphetamine flag is completely artifactual, caused by the promethazine fooling the antibodies in the test kit, not by any actual amphetamine-class drug in the urine.

Confirmatory testing clears up the false amphetamine positive, because mass spectrometry can tell promethazine from methamphetamine with certainty. But confirmatory testing is not always performed, or it may take days to come back. In the meantime, a dual positive for opiates and amphetamines looks worse on paper than a single opiate positive, and it can create complications in legal and employment settings where preliminary results carry weight.

How Long Lean Stays Detectable in Urine

Detection windows depend on the drug, the dose, and the sensitivity of the test. For codeine specifically, research using immunoassays set at the 300 nanogram-per-milliliter cutoff found average detection times ranging from about 33 to 54 hours after a codeine dose.⁴ That roughly translates to one and a half to just over two days. Some individuals clear codeine metabolites faster, others slower, depending on factors like hydration, kidney function, body mass, and the amount consumed. A person who drinks lean heavily or repeatedly will accumulate more metabolite and push the detection window longer.

Promethazine has an elimination half-life of roughly 10 to 14 hours, meaning the body clears half of it every 10 to 14 hours.⁵ Trace amounts and metabolites can persist in urine beyond that window, so the false-positive amphetamine risk does not disappear the moment the sedation wears off. Someone who drank lean on a Friday night could still have enough promethazine metabolites in their system on Sunday or Monday to interfere with an immunoassay.

Hair testing extends the window dramatically for codeine, potentially to 90 days, because drug metabolites become trapped in the hair shaft as it grows. Hair panels are less common in routine workplace testing but are standard in some legal and child-custody contexts. Oral fluid (saliva) tests have a shorter window than urine, generally 24 to 48 hours for most opioids, and are increasingly used in roadside or point-of-care settings.

The Poppy Seed Problem and Confirmatory Nuances

One complication with opiate testing is that codeine can show up in urine from sources that have nothing to do with lean or any prescription drug. Poppy seeds contain trace amounts of naturally occurring opiates. In a controlled feeding study, about a third of urine samples collected after participants ate commercially available poppy-seed-containing foods tested positive for codeine at the 300 nanogram-per-milliliter cutoff.⁶ A portion of those samples were positive for codeine but negative for morphine at the same cutoff, meaning the morphine-to-codeine ratio looked different from what you would expect in a person who took codeine directly.

This ratio matters because toxicologists use it to help distinguish between different sources of opiates in the urine. When someone metabolizes codeine normally, they produce both codeine and a predictable amount of morphine. Poppy seed ingestion tends to produce a different metabolite profile. In theory, this should help labs tell the difference between a lean user and someone who ate a poppy seed bagel. In practice, the overlap is messy enough that the topic remains debated among forensic toxicologists. The federal workplace cutoff for opiates was raised specifically because of the poppy seed problem, but even the higher cutoff does not eliminate every edge case.

Genetic Differences That Change the Picture

Not everyone metabolizes codeine the same way. The enzyme CYP2D6, which converts codeine to morphine, is highly variable across the population. Clinical guidelines divide people into groups based on how active their CYP2D6 enzyme is. People classified as poor metabolizers have very little CYP2D6 activity, so they convert almost no codeine into morphine. People at the other extreme, ultrarapid metabolizers, convert codeine into morphine much faster and more completely than average.⁷

This genetic variation has real consequences for drug testing. A poor metabolizer who drinks lean will excrete mostly codeine in their urine, with relatively little morphine. An ultrarapid metabolizer who drinks the same amount of lean will excrete proportionally more morphine and less unchanged codeine. The total opiate load in urine might also differ, because ultrarapid metabolizers can produce enough morphine to cause stronger and more prolonged effects from the same dose. Both metabolizer types will still test positive for opiates, but the metabolite ratios will look different to the lab, and the detection window could shift.

The genetic variation also has serious health implications that go beyond the drug test. Ultrarapid metabolizers face a higher risk of morphine toxicity from what seems like a moderate dose of codeine. Several fatal overdoses have been linked to this genetic pattern, including cases involving children and breastfeeding infants whose mothers were ultrarapid metabolizers taking prescribed codeine.² Someone drinking lean without knowing their CYP2D6 status is, in a sense, gambling on their genetic makeup determining whether the dose is mild or dangerous.

When Lean Contains More Than Expected

Street-sourced lean is not a controlled pharmaceutical product. The forensic analysis of confiscated dirty sprite samples found not only the expected codeine and promethazine but also impurities of cocaine in one sample and dihydrocodeine in another.¹ The presence of cocaine, even at trace levels, would trigger an entirely separate panel on a drug test, one that the user might not have anticipated at all.

Dihydrocodeine, which showed up in another sample, is a different opioid that metabolizes along its own pathway. Its metabolites can cross-react with opiate immunoassays in the same way codeine does, but the confirmatory fingerprint will differ. A toxicologist reviewing the results might see an unexpected metabolite pattern that does not match straightforward codeine use, which could raise questions in a forensic or legal setting.

Some lean recipes substitute over-the-counter cough syrups containing dextromethorphan (DXM) for the harder-to-obtain prescription codeine-promethazine formulation. DXM is not an opioid and does not typically trigger the opiate panel. However, DXM is metabolized through some of the same liver enzymes as codeine, and at high doses it can produce its own set of cross-reactivity issues with certain immunoassay platforms. DXM’s primary metabolite, dextrorphan, can cross-react with phencyclidine (PCP) assays on some test kits, creating yet another flavor of false positive. The pharmacokinetics of DXM are also affected by CYP2D6 genetic variation, meaning the same population variability that shapes codeine metabolism influences DXM metabolism as well.⁸

The Health Risks Beyond a Positive Test

A drug test result is usually the least serious consequence of drinking lean. The combination of codeine and promethazine produces respiratory depression from two directions simultaneously. Codeine, through its conversion to morphine, slows breathing via opioid receptors. Promethazine, through its antihistamine and anticholinergic effects, adds its own sedation and can potentiate the respiratory depression caused by the opioid. This synergy is the whole point of the drink’s formulation, but it is also what makes it dangerous.

An analysis of adverse drug reaction reports submitted to the European Medicines Agency found that more than half of promethazine abuse and misuse cases involved fatalities, and opioids were the most commonly reported drugs used alongside promethazine in those deaths.⁹ The combination of an opioid and a potent sedating antihistamine is recognized as a particularly high-risk pattern for overdose, even when the opioid involved is codeine rather than something stronger like fentanyl or oxycodone.

Lean use also comes with the risk of physical dependence. Codeine, like all opioids, produces tolerance with repeated use, meaning the same amount stops producing the desired effect and users escalate their intake. Promethazine dependence is less well-characterized, but the European reporting data identified dependence as a documented outcome in a subset of cases.⁹ Seizures on withdrawal, severe constipation from chronic opioid use, and liver damage from the large volumes of acetaminophen sometimes present in combination cough syrups round out a list of health concerns that make the drug test question feel almost trivially small by comparison.

What Happens If You Disclose a Prescription

Codeine-promethazine cough syrup is a legitimate prescription medication. If you have a valid, current prescription for it and can document that with the medical review officer (MRO) who oversees the drug testing process, a positive opiate result can be adjudicated as consistent with prescribed use. The MRO’s role is specifically to evaluate positive results in context, contact the donor, verify prescriptions, and determine whether the result should be reported as positive or negative to the employer or requesting authority.

The catch is that lean use almost always involves quantities well beyond prescribed dosing. A typical prescription might call for one or two teaspoons every four to six hours, while lean recipes involve pouring several ounces of syrup into a drink. If the MRO notes that the codeine and morphine concentrations in the sample are far higher than what prescribed use would produce, that raises questions even with a valid prescription. And if there is no prescription at all, there is no defense to offer. The result stands as a confirmed positive for codeine and morphine.

The false-positive amphetamine issue from promethazine does have a cleaner resolution, at least in testing programs that follow up with confirmation. Since confirmatory mass spectrometry will not find any actual amphetamine or methamphetamine in the sample, the amphetamine positive gets reclassified as negative. The opiate positive, however, remains exactly what it is.

Global Spread and Changing Formulations

Lean originated in the Houston hip-hop scene in the 1960s and has since spread well beyond the United States. Researchers have documented its use among teenagers across Europe, South America, and Asia, where it goes by region-specific names.¹⁰ In Thailand, for instance, the drink is known as “ya pro” or “ya lean.” As the drink has migrated globally, its formulation has become less standardized. Different countries have different prescription drug regulations, different cough syrup formulations available on shelves, and different adulterants that find their way into street preparations.

This matters for drug testing because the specific substances a person is exposed to depend on what went into their particular batch. A lean drink made in a country where codeine is available over the counter might contain codeine but not promethazine. A preparation made with diverted veterinary codeine could contain different impurities than one made with pharmaceutical-grade syrup. The forensic analysis of confiscated samples has already shown that real-world lean is not a single standardized product but a variable mixture, and the drug test implications shift accordingly. What remains constant is that any formulation containing codeine will produce a positive opiate result, and the metabolite trail it leaves will be identifiable to anyone looking for it.